Dr. Chin, an oncology specialist, most recently served as senior vice president and head of clinical development at 2Seventy Bio, a biotechnology company, according to a March 1 news release from Marengo.
In his new role, Dr. Chin will manage the development of the company’s clinical portfolio, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.